Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Numerous stakeholders have repeatedly called for improved health IT interoperability as a first step to improved healthcare but the Government Accountability Office (GAO) just released a report identifying ongoing barriers.
The Department of Health and Human Services Secretary will award $685 million to 39 national and regional healthcare networks and supporting organizations to help equip clinicians with the tools and support needed to improve quality of care, increase patients’ access to information and reduce costs.
The latest Centers for Medicare & Medicaid Services (CMS) funding will go toward efforts to reduce preventable hospital-acquired conditions and readmissions.
The FDA has created the Patient Engagement Advisory Committee which will provide advice to the FDA commissioner on a range of complex issues relating to medical devices, the regulation of devices and their use by patients.
Most people will experience at least one diagnostic error in their lifetime, according to a new report from the Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine.
The Office of the National Coordinator for Health IT (ONC) is seeking public comments on the draft 2016 Interoperability Standards Advisory.
Getting motivating and informative text messages led patients with coronary heart disease to make behavior changes like exercising more and smoking less with concrete results, according to a study published in JAMA, the journal of the American Medical Association.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.